News for BioMarin Pharmaceutical Inc. (0HNC.L)

Insight into Biomarin's robust product portfolio and expanding pipeline.Analysis of Biomarin's financial resilience and strategic growth initiatives.Understand

PR NewswireSAN RAFAEL, Calif., Feb. 24, 2025 SAN RAFAEL, Calif., Feb. 24, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2024 Earnings Conference Call February 19, 2025 4:30 PM ETCompany ParticipantsTraci McCarty - Head of...

The following slide deck was published by BioMarin Pharmaceutical Inc.

We recently compiled a list of the Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc (BMRN) announced on January 6, 2025, that its President and CEO, Alexander Hardy, will present at the 43rd Annual J.P. Morgan Health

PR NewswireSAN RAFAEL, Calif., Jan. 6, 2025 SAN RAFAEL, Calif., Jan. 6, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced th

Sangamo Therapeutics Inc. shares fell the most in 16 years after Pfizer Inc. ended the two companies’ partnership to develop a new gene therapy to treat hemophilia A. Sangamo is considering “all options” to continue developing the drug, including finding a new partner, the company said in a statement Monday.…

Sangamo Therapeutics Inc. (SMO), a genomic medicine company, experienced a major setback as Pfizer Inc. (PFE) terminated their collaboration on a groundbreaking gene therapy for hemophilia A. The abrupt end to this partnership triggered Sangamo’s largest single-day share drop in more than 15 years. The decision came unexpectedly, with Sangamo's…

212 firms in the S&P 1500 have not beaten even US treasuries over the last 10 years

Analyzing the Latest N-PORT Filing for Q3 2024 Elfun Trusts (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2024, shedding li

We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc.

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc.

Genomics is the study of genes and how they function.

Nabeel Bhanji, a London-based partner at Elliott Investment Management who worked on some of the activist investment firm’s most high-profile campaigns, is leaving …

Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents

Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. One of the most popular technical indicators for helping investors find these is the Relative Strength Index (RSI).

As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1," the size of the global biotechnology industry was assessed to be worth $1.38 trillion in 2023 and is expected to grow at ...

Portfolio of Oral Selective α4β7 Inhibitors Acquired from EA Pharma, Eisai’s GI Subsidiary Phase 2 Clinical Program in Ulcerative Colitis to Start in...